Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00629
|
|||||
| Drug Name |
Aldosterone
|
|||||
| Synonyms |
(+)-Aldosterone; (11BETA)-11,21-DIHYDROXY-3,20-DIOXOPREGN-4-EN-18-AL; (8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde; 11.beta.,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al; 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 18,11-halbacetal; 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione; 11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al; 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al; 18-Aldocorticosterone; 18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione; 18-Oxocorticosterone; Aldocorten; Aldocortene; Aldocortin; Aldosterona; Aldosterona [INN-Spanish]; Aldosterone [INN:BAN:DCF]; Aldosterone, (+-)-Isomer; Aldosterone, (11 beta,17 alpha)-Isomer; Aldosteronum; Aldosteronum [INN-Latin]; D-Aldosterone; Electrocortin; Elektrocortin; Reichstein X
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H28O5
|
|||||
| Canonical SMILES |
CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C=O)O
|
|||||
| InChI |
InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1
|
|||||
| InChIKey |
PQSUYGKTWSAVDQ-ZVIOFETBSA-N
|
|||||
| CAS Number |
CAS 52-39-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 360.4 | Topological Polar Surface Area | 91.7 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
1.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103174056
, 104310406
, 115922
, 12146619
, 123120918
, 124800418
, 126666510
, 128954713
, 134338558
, 134972910
, 135651432
, 137048176
, 141345016
, 14828271
, 160967623
, 163076031
, 172097284
, 175268093
, 178100450
, 24702310
, 24891458
, 26757653
, 29224871
, 3139122
, 46505770
, 48415527
, 48421925
, 4910
, 50019585
, 53789139
, 56310979
, 56311296
, 56311417
, 56312971
, 56313892
, 56314372
, 56320629
, 56320630
, 57322992
, 57392512
, 625873
, 77125022
, 7885975
, 7978658
, 8144488
, 8153606
, 841789
, 85845809
, 87219227
, 93165963
|
|||||
| ChEBI ID |
ChEBI:27584
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Aldosterone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | MDR1 genotype-dependent regulation of the aldosterone system in humans. Pharmacogenet Genomics. 2007 Feb;17(2):137-44. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.